Ocular Therapeutix, Inc

OCUL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001393434

SEC filings (opens in a new tab)

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Ocular Therapeutix, Inc changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of OCUL: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	180	2	197	+19
Shares	133.8M	414.3K	137.4M	+3.93M (+2.9%)
Value	$1.14B	$3.54M	$1.01B	−$132.4M (−11.6%)

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (35)

Institutions that held Ocular Therapeutix, Inc at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to OCUL in Q1 2025
Institution	Shares	Value	% of portfolio
Paradigm Biocapital Advisors LP	1,314,018	$9.63M	0.44%
Peregrine Capital Management LLC	847,468	$6.21M	0.21%
Silverarc Capital Management, LLC	551,570	$4.04M	0.84%
Renaissance Technologies LLC	454,000	$3.33M	0.01%
Nuveen, LLC	414,104	$3.04M	0.00%
Assenagon Asset Management S.A.	341,800	$2.51M	0.00%
Cubist Systematic Strategies, LLC	137,871	$1.01M	0.01%
StemPoint Capital LP	124,523	$912.8K	0.29%
Jane Street Group, LLC	105,049	$770.0K	0.00%
ExodusPoint Capital Management, LP	96,185	$705.0K	0.01%
Tudor Investment Corp Et Al	79,648	$583.8K	0.01%
Verition Fund Management LLC	70,430	$516.3K	0.00%
Warren Averett Asset Management, LLC	47,691	$349.6K	0.00%
Squarepoint Ops LLC	45,054	$330.2K	0.00%
Superstring Capital Management LP	42,297	$310.0K	0.37%
EntryPoint Capital, LLC	42,031	$308.1K	0.14%
Caxton Associates LLP	33,821	$247.9K	0.01%
Algert Global LLC	29,020	$212.7K	0.01%
Graypoint LLC	20,194	$148.0K	0.01%
Bayesian Capital Management, LP	17,000	$124.6K	0.02%
Gsa Capital Partners LLP	15,306	$112.0K	0.01%
Quantinno Capital Management LP	11,079	$81.2K	0.00%
Vontobel Holding Ltd.	10,784	$79.0K	0.00%
Point72 Asia (Singapore) Pte. Ltd.	8,629	$63.3K	0.02%
Point72 (DIFC) Ltd	5,077	$37.2K	0.00%
Financial Network Wealth Advisors LLC	2,638	$19.3K	0.03%
Signaturefd, LLC	781	$5.72K	0.00%
Massmutual Trust Co FSB	320	$2.35K	0.00%
The PNC Financial Services Group, Inc.	283	$2.07K	0.00%
Smartleaf Asset Management LLC	226	$1.71K	0.00%
Coldstream Capital Management Inc	70	$514	0.00%
Caitong International Asset Management Co., Ltd	69	$506	0.00%
Stephens Consulting, LLC	50	$367	0.00%
TD Capital Management LLC	47	$345	0.00%
EverSource Wealth Advisors, LLC	38	$279	0.00%

Sold out (16)

Institutions that held Ocular Therapeutix, Inc at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of OCUL in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Millennium Management LLC	447,237	$3.82M
Nantahala Capital Management, LLC	437,728	$3.74M
Paradigm Capital Management Inc	400,000	$3.42M
Hussman Strategic Advisors, Inc.	105,000	$896.7K
TD Asset Management Inc	60,000	$512.4K
Brevan Howard Capital Management LP	24,078	$205.6K
Freestone Grove Partners LP	13,931	$119.0K
Diversified Trust Co	12,239	$104.5K
Campbell & CO Investment Adviser LLC	12,071	$103.1K
Palumbo Wealth Management LLC	11,693	$99.9K
Walleye Capital LLC	10,548	$90.1K
Aster Capital Management (DIFC) Ltd	1,431	$12.2K
Clear Street Markets LLC	1,311	$11.2K
State of Wyoming	1,049	$8.96K
Bessemer Group Inc	160	$1.00K
Parallel Advisors, LLC	1	$9

Not filed for Q1 2025 yet (2)

Institutions that held Ocular Therapeutix, Inc at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OCUL in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	414,104	$3.54M
Global Retirement Partners, LLC	225	$1.92K